Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:20 pm Unchanged | 2022-12-31 | 13G | Gracell Biotechnologies Inc. GRCL | ORBIMED ADVISORS LLC | 5,970,672 8.800% | 0 (Unchanged) | Filing History |
| 2023-02-14 4:12 pm Unchanged | 2022-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | ORBIMED ADVISORS LLC | 3,196,876 5.900% | 0 (Unchanged) | Filing History |
| 2023-02-14 4:09 pm Sale | 2022-12-31 | 13G | Crescent Biopharma, Inc. CBIO | ORBIMED ADVISORS LLC | 0 0.000% | -3,424 (Position Closed) | Filing History |
| 2023-02-14 4:07 pm Purchase | 2022-12-31 | 13G | Applied Therapeutics, Inc. APLT | ORBIMED ADVISORS LLC | 7,300,921 9.990% | 5,200,240 (+247.55%) | Filing History |
| 2023-02-14 4:06 pm Purchase | 2022-12-31 | 13G | ALX Oncology Holdings Inc. ALXO | ORBIMED ADVISORS LLC | 2,266,000 5.600% | 2,266,000 (New Position) | Filing History |
| 2023-02-14 4:01 pm Sale | 2022-12-31 | 13G | Aeglea BioTherapeutics, Inc. AGLE | ORBIMED ADVISORS LLC | 71,889 2.900% | -86,356 (-54.57%) | Filing History |
| 2023-01-26 4:40 pm Sale | 2023-01-24 | 13D | 89bio, Inc. ETNB | ORBIMED ADVISORS LLC | 1,504,436 3.200% | -325,000 (-17.77%) | Filing History |
| 2023-01-05 4:40 pm Sale | 2023-01-03 | 13D | SpringWorks Therapeutics, Inc. SWTX | ORBIMED ADVISORS LLC | 4,985,000 8.000% | -614,842 (-10.98%) | Filing History |
| 2023-01-03 5:23 pm Purchase | 2022-12-29 | 13D | Disc Medicine, Inc. IRON | ORBIMED ADVISORS LLC | 2,160,941 12.800% | 2,160,941 (New Position) | Filing History |
| 2022-12-28 5:14 pm Purchase | 2022-12-23 | 13D | Terns Pharmaceuticals, Inc. TERN | ORBIMED ADVISORS LLC | 7,619,135 15.400% | 137,931 (+1.84%) | Filing History |
| 2022-12-27 4:36 pm Sale | 2022-12-22 | 13D | ORIC Pharmaceuticals, Inc. ORIC | ORBIMED ADVISORS LLC | 1,787,569 4.500% | -425,002 (-19.21%) | Filing History |
| 2022-12-27 4:25 pm Sale | 2022-12-22 | 13D | 89bio, Inc. ETNB | ORBIMED ADVISORS LLC | 4,260,691 5.600% | -767,483 (-15.26%) | Filing History |
| 2022-11-30 4:23 pm Sale | 2022-11-08 | 13D | ARS Pharmaceuticals, Inc. SPRY | ORBIMED ADVISORS LLC | 7,788,510 8.300% | -1 (-0.00%) | Filing History |
| 2022-11-29 4:27 pm Purchase | 2022-11-25 | 13D | scPharmaceuticals Inc. SCPH | ORBIMED ADVISORS LLC | 5,559,528 16.300% | 762,380 (+15.89%) | Filing History |
| 2022-11-25 4:57 pm Sale | 2022-11-22 | 13D | TRICIDA INC TCDAQ | ORBIMED ADVISORS LLC | 666,667 1.100% | -8,951,245 (-93.07%) | Filing History |
| 2022-11-10 4:25 pm Purchase | 2022-11-08 | 13D | Compass Therapeutics, Inc. CMPX | ORBIMED ADVISORS LLC | 18,791,422 14.900% | 719,875 (+3.98%) | Filing History |
| 2022-11-07 4:25 pm Unchanged | 2022-11-03 | 13D | Keros Therapeutics, Inc. KROS | ORBIMED ADVISORS LLC | 1,268,734 4.600% | 0 (Unchanged) | Filing History |
| 2022-09-28 4:23 pm Purchase | 2022-09-19 | 13D | Third Harmonic Bio, Inc. THRD | ORBIMED ADVISORS LLC | 5,779,071 14.300% | 5,779,071 (New Position) | Filing History |
| 2022-09-27 4:29 pm Sale | 2022-09-23 | 13D | Alpine Immune Sciences, Inc. ALPN | ORBIMED ADVISORS LLC | 4,081,592 9.300% | -145,251 (-3.44%) | Filing History |
| 2022-09-16 4:23 pm Purchase | 2022-09-16 | 13D | Edgewise Therapeutics, Inc. EWTX | ORBIMED ADVISORS LLC | 14,301,551 23.300% | 622,496 (+4.55%) | Filing History |